Search Results - Cor van den Bos

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    BISPHOSPHONATES IN LANGERHANS CELL HISTIOCYTOSIS: AN INTERNATIONAL RETROSPECTIVE CASE SERIES by Deepak Chellapandian, Polyzois Makras, Gregory Kaltsas, Cor van den Bos, Lamia Naccache, Raajit Rampal, Anne-Sophie Carret, Sheila Weitzman, R. Maarten Egeler, Oussama Abla

    Get full text
    Article


  2. 2

    Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI by Ruben D. de Ruiter, M. Suzanne Gordijn, Reinoud J. B. J. Gemke, Cor van den Bos, Marc B. Bierings, Joost Rotteveel, Jan W. Koper, Elisabeth F. C. van Rossum, Gertjan L. Kaspers

    Published in Haematologica (2014-08-01)
    Get full text
    Article


  3. 3

    Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial by Kirsten A. Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Marta Fiocco, Heidi Segers, Cor van den Bos, Inge M. van der Sluis, Wim J.E. Tissing, Margreet A. Veening, Christian Michel Zwaan, Cornelis M. van Tilburg, Rob Pieters, Marc Bierings

    Published in Haematologica (2024-08-01)
    Get full text
    Article


  4. 4

    Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms by Astrid G. S. van Halteren, Paul G. Kemps, Jelske Forma-Borst, Yanling Xiao, Maud A. J. I. van den Oetelaar, Nina U. Gelineau, Robert M. Verdijk, Lydia E. Vos, Koen D. Quint, Cor van den Bos, Eli L. Diamond, Jan A. M. van Laar

    Published in Blood Neoplasia (2025-05-01)
    Get full text
    Article


  5. 5

    Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Neth... by Wim J E Tissing, Martha A Grootenhuis, Raphaële R L van Litsenburg, Gertjan J L Kaspers, Emily R Schwartz, Niki Rensen, Lindsay M H Steur, Reinoud Gemke, Natasha K A van Eijkelenburg, Inge M van der Sluis, Natasja Dors, Cor van den Bos

    Published in BMJ Open (2023-10-01)
    Get full text
    Article


  6. 6

    Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients by Sebastiaan D.T. Sassen, Ron A.A. Mathôt, Rob Pieters, Robin Q.H. Kloos, Valérie de Haas, Gertjan J.L. Kaspers, Cor van den Bos, Wim J.E. Tissing, Maroeska te Loo, Marc B. Bierings, Wouter J.W. Kollen, Christian M. Zwaan, Inge M. van der Sluis

    Published in Haematologica (2017-03-01)
    Get full text
    Article


  7. 7

    Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis by Paul G. Kemps, Timo C. Zondag, Eline C. Steenwijk, Quirine Andriessen, Jelske Borst, Sandra Vloemans, Dave L. Roelen, Lenard M. Voortman, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Cynthia Hawkins, Veronica Lang, Arnoud H. de Ru, George M. C. Janssen, Geert W. Haasnoot, Kees L. M. C. Franken, Ronald van Eijk, Nienke Solleveld-Westerink, Tom van Wezel, R. Maarten Egeler, R. Maarten Egeler, Auke Beishuizen, Auke Beishuizen, Jan A. M. van Laar, Oussama Abla, Cor van den Bos, Cor van den Bos, Peter A. van Veelen, Astrid G. S. van Halteren, Astrid G. S. van Halteren

    Published in Frontiers in Immunology (2020-01-01)
    Get full text
    Article


  8. 8

    Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis) by Aniek Uittenboogaard, Marleen H. van denBerg, Floor C. H. Abbink, Jos W. R. Twisk, Inge M. van derSluis, Cor van denBos, Marry M. van denHeuvel‐Eibrink, Heidi Segers, Christophe Chantrain, Jutte van derWerff ten Bosch, Leen Willems, Gertjan J. L. Kaspers, Mirjam Esther van deVelde

    Published in Cancer Medicine (2023-10-01)
    Get full text
    Article


  9. 9

    Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis by Francesco Pegoraro, Francois Chalard, Dmitry Evseev, Mohamed Barkaoui, Solenne Le Louet, Julian Thalhammer, Nathalie Aladjidi, Alexandra Salmon, Perrine Marec‐Berard, Stefania Gaspari, Carmela De Fusco, Irene Trambusti, Antonio Verrico, Anna Raciborska, Karel Svojgr, Zdenka Křenová, Olga Slater, Gerard Millen, Myriam Ben Arush, Dana Ashkenazi Lustig, Tatiana Von Bahr Greenwood, Caroline Hutter, Itziar Astigarraga, Mónica López‐Duarte, Lorena Valero‐Arrese, María José Ortega Acosta, Cor van den Bos, Leonie Naeije, Daniel Martin‐Munoz, Anna Perrone, Marzia Mortilla, Olivier Felician, Ahmed Idbaih, Sébastien Héritier, Vasanta Nanduri, Milen Minkov, Jan‐Inge Henter, Elena Sieni, Jean Donadieu

    Published in HemaSphere (2026-06-01)
    Get full text
    Article


Search Tools: